Cargando…

Identification of three ADA2 deficiency families with novel CECR1 mutations

Detalles Bibliográficos
Autores principales:	Sarrabay, G, Insalaco, A, Uettwiller, F, Tieulié, N, Quartier-dit-maire, P, Melki, J, Touitou, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599356/ http://dx.doi.org/10.1186/1546-0096-13-S1-P153

Ejemplares similares

ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters
por: Uettwiller, F, et al.
Publicado: (2016)

A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency
por: Nicoară, Delia, et al.
Publicado: (2023)

Update on CECR1 molecular diagnostics: new mutations in the deficiency of ADA2 (DADA2) and the North American polyarteritis nodosa (PAN) cohort
por: Stoffels, M, et al.
Publicado: (2015)

Prevalence of CECR1 mutations in pediatric patients with polyarteritis nodosa, livedo reticularis and/or stroke
por: Caorsi, R, et al.
Publicado: (2015)

Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation
por: Skrabl-Baumgartner, Andrea, et al.
Publicado: (2017)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

CECR1 p.Gly47Arg mutations are not increased in frequency in Turkish Behçet's disease patients compared with healthy controls
por: Erer, B, et al.
Publicado: (2015)

Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014)

Distinct cerebrovascular features in patients with ADA2 deficiency
por: Severino, MS, et al.
Publicado: (2015)

B cells characterization in ADA2 Deficiency patients
por: Schena, F, et al.
Publicado: (2015)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

Monogenic polyarteritis nodosa caused by ADA2 Deficiency: the GOSH experience
por: Nanthapisal, S, et al.
Publicado: (2015)

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013)

Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015)

PReS-FINAL-2231: A series of 41 mutations of TNFRAF1A
por: Chastang, MC, et al.
Publicado: (2013)

OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
por: Zhou, Q, et al.
Publicado: (2013)

A case with febrile attacks and vasculopathy associated with ADA2 and MEFV gene mutations
por: Ozdogan, H, et al.
Publicado: (2015)

NGS for the diagnosis of autoinflammatory diseases: the experience of Montpellier
por: Sarrabay, G, et al.
Publicado: (2015)

Mutations in CECR1 associated with a neutrophil signature in peripheral blood
por: Belot, Alexandre, et al.
Publicado: (2014)

First report of MEFV duplication in FMF patient
por: Sarrabay, G, et al.
Publicado: (2015)

Novel pathogenic ADA2 mutations: alert to diagnosis challenge of ADA2 deficiency
por: Wu, Zhijie, et al.
Publicado: (2023)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations
por: Van Montfrans, J, et al.
Publicado: (2015)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

The clinical spectrum of 94 French patients carrying a single mutated MEFV allele
por: Koné-Paut, I, et al.
Publicado: (2008)

Three cases report of resistance to thyroid hormone and the genetic mutation of these patients and their family members
por: Gu, Yi, et al.
Publicado: (2013)

Mevalonate kinase deficiency (MKD): long-term follow-up of clinical and biological features in 40 patients
por: Florkin, B, et al.
Publicado: (2008)

PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome
por: Insalaco, A, et al.
Publicado: (2013)

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

Non-infectious pediatric uveitis in a single french tertiary center
por: Nouar, Dalila, et al.
Publicado: (2014)

Identification of a novel familial FGF16 mutation in two cases of MF4
por: Jones, B, et al.
Publicado: (2015)

Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
por: Jeyaratnam, J, et al.
Publicado: (2015)

Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occurring in systemic juvenile idiopathic arthritis (sJIA)
por: Bracaglia, Claudia, et al.
Publicado: (2014)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

Familial lipoprotein lipase deficiency – neonatal presentation
por: Siu-ying, Nip
Publicado: (2015)

Cecr2 mutant mice as a model for human cat eye syndrome
por: Dicipulo, Renée, et al.
Publicado: (2021)

L'essentiel du CECR pour les langues : le Cadre européen commun de référence pour les langues
por: Lallement, Brigitte
Publicado: (2015)

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
por: Insalaco, A, et al.
Publicado: (2013)

Clinical heterogeneity among a three-generation Japanese family with D18N TREX1 mutation for Aicardi-Goutières syndrome / familial chilblain lupus
por: Abe, J, et al.
Publicado: (2011)

Proerythroblast Cells of Diamond-Blackfan Anemia Patients With RPS19 and CECR1 Mutations Have Similar Transcriptomic Signature
por: Karaosmanoglu, Beren, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ejkrmor0n61rvvrir9g66ps598